Dld Asset Management, LP Biomarin Pharmaceutical Inc Put Options Transaction History

Dld Asset Management, LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $1.75 Million - $2.35 Million	20,000 Added 200.0%	30,000 $2.92 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $714,800 - $868,500	10,000 New	10,000 $829,000
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $2.43 Million - $3.8 Million	-30,600 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $742,248 - $1.01 Million	-10,400 Reduced 25.37%	30,600 $2.59 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $899,780 - $1.21 Million	14,000 Added 51.85%	41,000 $3.47 Million
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $404,400 - $510,660	6,000 Added 28.57%	27,000 $1.82 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $522,274 - $610,350	-6,500 Reduced 23.64%	21,000 $1.8 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $2.32 Million - $2.71 Million	27,500 New	27,500 $2.44 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.